DUK
42
3
FMC
43
3
IP
51
3
BDX
46
11
MU
47
-7
AMAT
52
-2
STX
37
-2
TMO
54
-2
EXPE
50
-12
XYL
49
4
NUE
47
-3
AEP
34
5
CCL
33
2
CHD
59
-2
LLY
57
-2
VLO
30
-6
TRIP
50
-2
CINF
50
5
CPB
47
2
CF
26
5
DUK
42
3
FMC
43
3
IP
51
3
BDX
46
11
MU
47
-7
AMAT
52
-2
STX
37
-2
TMO
54
-2
EXPE
50
-12
XYL
49
4
NUE
47
-3
AEP
34
5
CCL
33
2
CHD
59
-2
LLY
57
-2
VLO
30
-6
TRIP
50
-2
CINF
50
5
CPB
47
2
CF
26
5
Financhill
Back

Berkshire Hathaway Vs. Akero Therapeutics Industry Stock Comparison

Sell
49

BRK.A
Berkshire Hathaway

Last Price:
607,900.00
Seasonality Move:
3.81%
Sell
28

AKRO
Akero Therapeutics

Last Price:
20.56
Seasonality Move:
16.32%
Sell
49
Berkshire Hathaway (BRK.A) is a Sell

Is Berkshire Hathaway a Buy, Sell or Hold?

  • The current Berkshire Hathaway [BRK.A] share price is $604,144.00. The Score for BRK.A is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $20.53. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRK.A Stock Price Chart

What is Berkshire Hathaway's stock price today?

  • The Berkshire Hathaway share price today is $604,144.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing slight buying pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $20.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3023.13 Sell
Relative Strength Index (14 RSI): 39.45 Sell
Chaikin Money Flow: 2682 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (620709.75 - 620729.75) Sell
Bollinger Bands (100): (585132.89 - 585196.89) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 31.06 Sell
Chaikin Money Flow: -466037 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.03 - 25.77) Sell
Bollinger Bands (100): (19.59 - 26.15) Sell

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 609714.38 Sell
20-day SMA: 620915.65 Sell
50-day SMA: 615162.52 Sell
200-day SMA: 559804.86 Buy
8-day EMA: 608802.47 Sell
20-day EMA: 615238.77 Sell
50-day EMA: 608870.45 Sell
200-day EMA: 563875.96 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.92 Sell
20-day SMA: 23.23 Sell
50-day SMA: 24.56 Sell
200-day SMA: 29.56 Sell
8-day EMA: 21.85 Sell
20-day EMA: 23.1 Sell
50-day EMA: 23.86 Sell
200-day EMA: 27.89 Sell

Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $454.62 per share, an increase next quarter of $269.19 per share, an increase this year of $1,563.62 per share, and an increase next year of $1,688.58 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.

Berkshire Hathaway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):